Dear Label_Name,

Greetings! I hope you are well.

I am writing on behalf of an international publishing house, Science and Education Publishing, USA (http://www.sciepub.com).

Science and Education Publishing (SciEP) is a multidisciplinary open access publisher of Journals covering the fields of Science, Technology and Medicine. All SciEP publications are subject to high-quality peer review, editorial and production processes and are freely available online.

Welcome to the April, 2013 edition of SciEP newsletter, providing monthly summaries of articles on science & education related topics of interest to scientist and professionals. The mission of our journals is to provide an open access forum for publishing new findings on issues pertinent to scientific and academic field. We also invite you to submit original research papers, review articles, short reports, or case studies are considered for publication in our Multidisciplinary Journals.

American Journal of Public Health Research
DOI: 10.12691/ajphr-1-1-3

The Implementation of a Tele-Homecare System with Service Oriented Architecture and HL7 Message Transmission Standard
Ching-Sung Wang

American Journal of Medical and Biological Research
DOI: 10.12691/ajmbr-1-1-2

The Influence of Ethanol on Pyruvate Kinases Activity in Vivo, in Vitro, in Silico
Lelevich Sergey Vladimirovich, Khrustalev Vladislav Victorovich, Barkovsky Eugene Victorovich, Shedogubova Tatyana Aleksandrovna

American Journal of Medical Sciences and Medicine
DOI: 10.12691/ajmsm-1-1-1

Clinical and Histological Features in Wegener Granulomatosis
Li Cavoli Gioacchino, Passantino Rita, Bono Luisa, Tortorici Calogera, Ferrantelli Angelo, Giammarresi Carlo, Rotolo Ugo

American Journal of Infectious Diseases and Microbiology
DOI: 10.12691/ajidm-1-1-2

The Curse of Lymphatic Filariasis: Would the Continual Use of Diethylcarbamazine Eliminate this Scourge in Papua New Guinea?
Anne Lanham, Lillian Mwanri

We have released issues of some journals on February 2013.
American Journal of Public Health Research
American Journal of Medical Sciences and Medicine
American Journal of Medical and Biological Research
American Journal of Pharmacological Sciences
American Journal of Clinical Medicine Research
American Journal of Nursing Research
American Journal of Cancer Prevention
American Journal of Medicine Studies
American Journal of Infectious Diseases and Microbiology
American Journal of Cardiovascular Disease Research
American Journal of Biomedical Research
American Journal of Mechanical Engineering
American Journal of Microbiological Research
Journal of Preventive Medicine
American Journal of Food and Nutrition
American Journal of Hypertension Research
American Journal of Sports Science and Medicine
Journal of Cancer Research and Treatment
American Journal of Zoological Research
Journal of Biomedical Engineering and Technology
American Journal of Microbiological Research
Biomedical Science and Engineering

We are pleased to announce that submissions are now being accepted for peer review for all the journals across all our subject areas in SciEP.

Please submit your manuscript via our online submission system:
http://www.sciepub.com/author/signin

To unsubscribe from our mailing list, please click on the following link: unsubscribe

I am looking forward to hearing from you.

Kind regards,

David Rain
Email:join@sciepub.com
Science and Education Publishing (http://www.sciepub.com)

Prothrombin Time, Activated partial Thromboplastin Time and Platelets Count in Pregnant Females and Postpartum Period with Deep Venous Thrombosis

Huda I. Babiker, Hiba A. Awooda, Sana E. Abdalla*

Medical Researches, Faculty of Medicine Center, Alneelin University, Khartoum, Sudan

Abstract: Background: Venous thromboembolism is one of the major causes of maternal morbidity and mortality, the aims of this work was to determine the levels of (Prothrombin time (PT), activated partial thromboplastin time (APTT) and platelets count (PLts)) in pregnant and postpartum when affected with deep venous thrombosis (DVT). Methods: Fifty female of child bearing age (15-45) years presented with signs of (DVT) either during pregnancy or postpartum period were investigated for PT, APTT and Plts count and fifty other pregnant and postpartum presented without signs of DVT were included as control groups, the patients females and control completed questionnaire of personal data and clinical history such as age, case study (pregnant or postpartum), usage of contraceptive pills and family history of DVT and number of pregnancies. The automated method used to measure PT, APTT, coagulomator and PLTs count using (sysmex K21). Results: Distribution of bleeding profile according to age groups showed that, mean of platelets count was higher (286.7) in young age (15-25 yrs.), PT was prolonged in vast majority of case group (90%), while it was normal in 10% of study population. APTT was prolonged in 62% of patients, mostly higher in third trimester with percentage of 69.4%. Platelets count found normal in vast majority of patients in all 3 trimesters. Conclusion: Normal platelet level where found in both control and case, while PT is significally prolonged in the case (P=0.00). While APTT is also prolonged in the case group; but not statistically significant with the control.

Keywords: Prothrombin, Thromboplastin, Platelets, thrombosis

Received November 01, 2014; Revised November 14, 2014; Accepted November 24, 2014

Citation: Huda I. Babiker, Hiba A. Awooda, Sana E. Abdalla, Prothrombin Time, Activated partial Thromboplastin Time and Platelets Count in Pregnant Females and Postpartum Period with Deep Venous Thrombosis. International Journal of Hematological Disorders, 1 (1). 41-44. January 2014. doi:10.12691/ijhd-1-1-8

1. Introduction

Venous thromboembolism (VTE) is a serious complication that increases throughout pregnancy and Postpartum Period with estimated incidence rate of 1 per 1000 pregnancies [1]. Moreover; Pregnancy itself is an independent risk factor for VTE and it was reported that women develop VTE five times more than when not pregnant [2].

Haemostasis in normal pregnancy involves a complex network of interactions with positive and negative feedback loops, integrating blood vessels; platelets, coagulation factors, coagulation inhibitors and fibrinolysis; all these has evolved the likely to protect women from hemorrhage during miscarriage or childbirth. These multiple changes occur in the coagulation system may contribute in the hypercoagulibity state and results in the following: endothelial injury together with decrease fibrinolysis and reduced levels of the natural antifibrinolysis [3,4].

Most of women who develop thrombosis during pregnancy presented with edema and skin changes to recurrent thromboses and ulceration [5]. VTE during pregnancy may results in poor pregnancy outcome such as placental abruption, preeclampsia, fetal growth restriction, stillbirth, and possibly recurrent miscarriage [6,7,8].

Sometimes death due to VTE is so rapid that it leaves insufficient time for intervention. Patients at risk must be identified and given appropriate prophylaxis to reduce VTE-related mortality and mortality and improve the outcome of pregnancy. The failure to reduce this rate may be a result of uncertainty regarding risk factors for VTE and the associated difficulty in recognizing individuals at risk. Reported risk factors vary widely as do the genetic, environmental and behavioral factors [9,10].

Risk of thrombo-embolism was increased because of medical practices such as operative (caesarean or instrumental) delivery, prescription of prolonged bed rest after delivery, and use of estrogens to suppress lactation [11].

Despite all above mention risks of interaction between thrombophilia and pregnancy, there is little published data regarding the circumstances surrounding VTE in pregnancy and post partum period. Hence; this study aimed to determine prothrombin time (PT), activated partial prothrombin time (APTT) and platelets count among pregnant females and postpartum period with DVT in Khartoum State as well as to explore the possible associate between them.

2. Material and Methods

2.1. Study Design

This is a case control hospital based study conducted the periods from August 2013 to May 2014.

2.2. Study Location

This study was undertaken in Omdurman maternity hospital and Khartoum teaching hospital in Khartoum state, Sudan.

2.3. Study Population

Fifty pregnant females and post partum patients of child – bearing age (15 – 45 years) presented with signs of DVT with confirmed by Doppler ultrasound were investigated for PT, APTT and platelet count other Healthy matched 50 pregnant females and post partum females of child – bleary age (15- 45 years) presented without signs of DVT as control group.

2.4. Inclusion and Exclusion Criteria

Inclusion criteria pregnant and post partum females presented with signs of DVT which confirmed by Doppler uterine sound, on anticoagulation with no other medical conditions. Exclusion criteria pregnant and post partum females presented with no signs of DVT and know cases of DVT under treatment were excluded from the study.

2.5. Data Collection

Data was collected using designed questionnaire including demographic data (age), gestational age, medical history and other information.

2.6. Sample Collection

Two and half ml of whole blood with 1:9 ratio of tri sodium citrate were collected from all participants, then centrifuged to take plasma to perform PT and APTT using automated coagulometer. Two and half ml of whole blood with ETDW anticoagulant collected to perform platelets count using automated haematological analyzer Sysmex K 21.

2.6.1. Determination of Prothrombin time (PT) and Activated Partial Thromboplastin Time (APTT)

Coulometer was used for measurement of PT and APTT automated are the same to as for manual method but cuvettes of one ml and magnetic stirrers used and time clot formation were recorded digitally [12].

Norma value of PT: (12-16 second) [13].

Norma value of APTT: (20-40 second)

2.6.2. Automation in PLT Counts

Sysemx K 21 was used for platelets count sample were counted automatically by PLT counted cu/mm [14] normal value: (150,000, 450,000 /cumm) [15].

2.7. Ethical Consideration

This study conforms to the ethical principles of medical research developed by the World Medical Association Declaration of Helsinki [16]. Ethical approval was taken from Research Esthetical Committee (REC) in the Federal Ministry Health (FMOH). Verbal consent was taken from all patients; explaining the objectives of the study.

2.8. Data Analysis

All data obtained with questionnaire and biochemical analysis were analyzed using the Statistical Package for the Social Sciences (SPSS) version 19. The chi square test was used to test distribution of categorical variables. The differences between test and control groups were assessed with the student's t test. Statistical significance was accepted when P value is ≤ 0.05.

3. Results

Table 1 illustrated the distribution of bleeding profile according to case and control groups, there was no significant difference between case and control regarding the mean of platelets counts (272.3+62 versus 271+70 respectively, p = 0.813). While the mean of PT in cases was significantly prolonged when compared to the control group (21.8+7.8 and 12.4+1.7 respectively; P = 0.000). In addition; the mean of APTT is prolonged but no statistical significant was found when compared to control group (62.2+ 21.2 and 38.5+63.3 respectively; P = 0.963).

As shown in Table 2 there were 36 females in the third trimester, 7 of them showed short prothrombin time < 12 secs, 11 with normal PT (12-16), while 18 females showed prolonged PT ≥ 16 secs. Moreover; 32 females were in the second trimester 5 females showed short PT, 12 with normal and 15 showed prolonged PT. 32 females in the first trimester, 6 showed short PT, 14 females with normal PT, while 12 shwed prolonged PT, while it is normal in control group.

In Table 3 There was prolonged APTT in 62% of patients distributed according to gestational age as follows: in the third trimester there was 25 patients with APTT > 40/ sec, in the first trimester 19 showed APTT more than 40 secs, while in the first trimester there was 19 patients had APTT more than 40/ sec. Correlation between gestational age and level of APTT showed no significant association (P value 0.96).

In addition; normal platelets counts found in 96.9% of patients in the first trimester, 96.9% in the second trimester and 94.4% in the third trimester Table 4.

Table 1. Mean of bleeding profile in case and control group

Table 2. Distribution of Prothrombin Time (PT) According to Gestational Age

Table 3. Distribution of APTT According to Gestational Age

Table 4. Distribution of Platelets count according to Gestational age

4. Discussion

In the current study comparison of platelets count between control and case groups showed no statistical difference between the two groups. While there was significant prolongation in the prothrombin time, also APTT in the control group was increased but to no significant difference found.

The results of the current study are supported by Hellgren M that proposed that during pregnancy there were increased endogenous thrombin generation, acquired activated protein C resistance and increased prothrombin level (PT) [17]. Another similar study in which they also measured Prothrombin fragments, by Cerneca F et al has shown that the parameters showing the greatest variation during pregnancy were PT, Prothrombin fragments F1+2, The existence of a hypercoagulable state in pregnancy was suggested by the increased levels of F1+2 [18].

In contrast to the our results; Lloyd R et al showed that Prothrombin time was decreased in pregnancy and it was associated with a significant increase in the activity of factors VII, VIII, IX, and X and in the concentrations of fibrinogen, -1-globulin, and -1-antitrypsin [19]. In another study by Hui C et al reported that Prothrombin time, activated partial thromboplastin time, thrombin time showed a tendency to decrease in pregnant women [20]. In addition; Szecsi PB et al; proposed that Prothrombin time remains unchanged in pregnancy, as well as the level of coagulation factors II, V, X, XI, XII and antithrombin, protein C largely remained unchanged [21].

Activated prothrombin times found higher among women in the third trimester with percentage of 62% mostly found in the third trimester with percentages of 25%, followed by 19% prolonged APTT in the first trimester and 18 patients in the second trimester; we found no statistical significant association. The study by Greer IA showed similar findings reporting that, DVT may lead to pulmonary embolism, the most common cause of maternal deaths in the developed countries; in the past, rates of fatal pulmonary embolism were highest in the post-partum period [22]. In addition; Sanka et al reported shortening of prothrombin time and activated partial thromboplastin time in the third trimester of pregnancy [23].

Platelets count found normal in vast majority of patients in all 3 trimesters, this is contradictory to study reported by Boehlen F et al that platelet count decreases in normal pregnancy possibly due to increased destruction and haemodilution with a maximal decrease in the third trimester [24].

5. Conclusion

This study concluded that there is prolonged PT and APTT in pregnant females and patients in postpartum period, while platelets count was found normal. Prolonged prothrombin times showed highly significant in association between and case and control groups, while there were insignificant prolonged PT and APTT in the third trimester among the study population.

Competing Interest

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Acknowledgment

We have collaborated with many colleagues for whom we have great regard.

References

[1]   | Phillips OP. Venous thromboembolism in the pregnant woman. J Reprod Med 2003; 48: 921-9.
[2]   | National Institutes of Health. Prevention of venous thrombosis and pulmonary embolism. NIH Consensus Development. JAMA 1986; 256: 744-9.
[3]   | Hull RD, Raskob GE, Carter CJ. SeriallPG in pregnant patients with clinically suspected deep vein thrombosis: 1990; 112: 663-7.
[4]   | World Health Organization. Maternal mortality in 2000: estimates developed by WHO, UNICEF and UNFPA. WHO; Geneva; 2004: 1-39.
[5]   | Bergqvist A, Bergqvist D, Lindhagen A, Matzsch T. Late symptoms after pregnancy-related deep vein thrombosis. Br J Obstet Gynaecol 1990; 97: 338-41.
[6]   | Pabinger I, Nemes L, Rintelen C, Koder S, Lechler E, Loreth RM et al. Pregnancy-associated risk for venous thromboembolism and pregnancy outcome in women homozygous for factor V Leiden. Hematol J 2000; 1: 37-41.
[7]   | Martinelli I, Legnani C, Bucciarelli P, Grandone E, De Stefano V, Mannucci PM. Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia. Thromb Haemost 2001; 86: 800-3.
[8]   | Middeldorp S, Libourel EJ, Hamulyak K, van der Meer J, Bu¨ ller HR. The risk of pregnancy-related venous thromboembolism in women who are homozygous for factor V Leiden. Br J Haematol 2001; 113: 553-5.
[9]   | Colman-Brochu S. Deep vein thrombosis in pregnancy. MCN Am J Matern Child Nurs. 2004; 29: 186-192.
[10]   | Hall JAG, Paut RM, Wilson KM. Maternal and fetal sequelaeb of anticoagulants during pregnancy. Am J Med 1980; 68: 122-40.
[11]   | Toglia MR, Weg JG. Venous thromboembolism during pregnancy. N Engl J Med 1996; 335 (2): 108-14.
[12]   | Hall JAG, Paut RM, Wilson KM. Maternal and fetal sequelaeb of anticoagulants during pregnancy. Am J Med 1980; 68: 122-40.
[13]   | Wessler S. Medical management of venous thrombosis. Ann Rev Med 1976; 27: 313.
[14]   | Raes DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995; 346: 1133-4.
[15]   | Ginsberg JS, Hirsh Rainbow AJ et al. Risks of the fetus radiological procedures used in the diagnosis maternal venous thromboembolic disease. Thromb Hemost 1989; 61: 189-96
[16]   | World Medical Association Medical Ethics Committee, Updating the WMA Declaration of Helsinki. Wld Med J 1999, 45: 11-13.
[17]   | Hellgren M. Hemostasis during normal pregnancy and puerperium. Semin Thromb Hemost. 2003 Apr; 29 (2); 125-30.

[18]  
Cerneca F, Ricci G, Simeone R, et al ‘Coagulation and fibrinolysis changes in normal pregnancy. Increased levels of procoagulants and reduced levels of inhibitors during pregnancy induce a hypercoagulable state, combined with a reactive fibrinolysis’ Eur J Obstet Gynecol Reprod Biol. 1997 May; 73 (1): 31-6.

[19]   | Lloyd R Whitfield, Amol S Lele, Gerhard Levy Amherst et al, Effect of Pregnancy on the relationship between concentration and anticoagulant action of heparin. Clinical Pharmacology and Therapeutics (1983) 34, 23-28; 1983.
[20]   | Hui C, Lili M, et al; Changes in coagulation and hemodynamics during pregnancy: a prospective longitudinal study of 58 cases. Arch Gynecol Obstet. 2012 May; 285 (5): 1231-6. Epub 2011 Nov 15. PMID: 22083312
[21]   | Szecsi PB, Jørgensen M, et al; Haemostatic reference intervals in pregnancy, Thromb Haemost. 2010 Apr; 103 (4): 718-27. Epub 2010 Feb 19. PMID: 2017476.
[22]   | Greer lA. Thrombosis in pregnancy: maternal and foetal issues. Lancet 1999; 353 (9160): 1258-65.
[23]   | Nihon Sanka Fujinka Gakkai Zasshi. A study of intrapartum and postpartum bleeding based on changes in blood coagulation and fibrinolysis during pregnancy. [Article in Japanese] 1987 Mar; 39 (3): 405-10. PMID: 3494090
[24]   | BoehlenF, HohlfeldP, Extermann Petal. Plate let count atterm pregnancy: are appraisal of the threshold. Obstet Gynecol 2000; 95: 29-33.